Transmedics Group - Stock

Transmedics Group Debt 2024

Transmedics Group Debt

111.39 USD

Transmedics Group Dividend yield

Ticker

TMDX

ISIN

US89377M1099

WKN

A2PH5P

In 2024, Transmedics Group's total debt was 111.39 USD, a -178.17% change from the -142.5 USD total debt recorded in the previous year.

Transmedics Group Aktienanalyse

What does Transmedics Group do?

Transmedics Group Inc is a company dedicated to the development and manufacturing of medical devices for organ transplantation. The company was founded in 1998 and is headquartered in Andover, Massachusetts, USA. Transmedics' business model is based on offering a unique and innovative technology for organ preservation during transport from donor to recipient. The patented Organ Care System (OCS) platform includes a range of state-of-the-art medical devices specifically designed for organ transport. Transmedics' Organ Care System includes three main devices: OCS Heart, OCS Lung, and OCS Liver. Each device is tailored for organ preparation and transport, providing individualized support based on the specific requirements of each organ and different transfer protocols. The OCS technology uses hypothermic (cold) perfusion to preserve the organ during transport. By continuously monitoring and supporting the organ's physiological functions, the OCS system can improve the survival rate of donor organs while reducing the time spent outside the body. Transmedics also offers comprehensive services, including the availability of OCS devices and qualified personnel to provide support throughout the transplantation process. Transmedics' customers include leading transplant centers and hospitals worldwide. The company works closely with these customers to ensure that its OCS devices meet the specific requirements of each transplantation program and help them achieve more successful transplantations. Transmedics' history is marked by a passion for improving transplantation medicine and saving lives through the provision of advanced technologies and solutions. The company has made significant progress in recent years and has experienced strong growth in all areas. Transmedics has also received a number of awards and recognition for its commitment to improving transplantation medicine. For example, in 2020, the company received the Red Herring Top 100 Global Award and was recognized for the seventh consecutive year as one of the fastest-growing companies by Deloitte. Overall, Transmedics is a leading provider of innovative medical devices for transplantation medicine. Through its organic technology and comprehensive service, the company supports transplant centers and hospitals worldwide in performing more successful transplantations and saving patients' lives. Transmedics Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Transmedics Group's Debt Structure

Transmedics Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Transmedics Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Transmedics Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Transmedics Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Transmedics Group Stock

What is the debt of Transmedics Group this year?

Transmedics Group has a debt level of 111.39 USD this year.

What was the debt of Transmedics Group compared to the previous year?

The debt of Transmedics Group has increased by -178.17% compared to the previous year dropped.

What are the consequences of high debt for investors in Transmedics Group?

High debt can pose a risk for investors of Transmedics Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Transmedics Group?

Low debt means that Transmedics Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Transmedics Group affect the company?

An increase in debt of Transmedics Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Transmedics Group affect the company?

A reduction in debt of Transmedics Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Transmedics Group?

Some factors that can influence the debt of Transmedics Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Transmedics Group so important for investors?

The debts of Transmedics Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Transmedics Group take to change the debt?

To change the debt, Transmedics Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Transmedics Group pay?

Over the past 12 months, Transmedics Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Transmedics Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Transmedics Group?

The current dividend yield of Transmedics Group is .

When does Transmedics Group pay dividends?

Transmedics Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Transmedics Group?

Transmedics Group paid dividends every year for the past 0 years.

What is the dividend of Transmedics Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Transmedics Group located?

Transmedics Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Transmedics Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Transmedics Group from 6/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did Transmedics Group pay the last dividend?

The last dividend was paid out on 6/7/2024.

What was the dividend of Transmedics Group in the year 2023?

In the year 2023, Transmedics Group distributed 0 USD as dividends.

In which currency does Transmedics Group pay out the dividend?

The dividends of Transmedics Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Transmedics Group

Our stock analysis for Transmedics Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Transmedics Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.